Invention Grant
US07872048B2 Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel
有权
用抑制NCCa-ATP通道的化合物治疗脊髓损伤的方法
- Patent Title: Methods for treating spinal cord injury with a compound that inhibits a NCCa-ATP channel
- Patent Title (中): 用抑制NCCa-ATP通道的化合物治疗脊髓损伤的方法
-
Application No.: US11229236Application Date: 2005-09-16
-
Publication No.: US07872048B2Publication Date: 2011-01-18
- Inventor: J. Marc Simard
- Applicant: J. Marc Simard
- Applicant Address: US MD Baltimore
- Assignee: University of Maryland, Baltimore
- Current Assignee: University of Maryland, Baltimore
- Current Assignee Address: US MD Baltimore
- Agency: Fulbright & Jaworski L.L.P.
- Main IPC: A61K31/64
- IPC: A61K31/64 ; A61K31/435 ; A61K31/198 ; A61K31/415
Abstract:
The present invention is directed to therapeutic compositions targeting the NCCa-ATP channel of an astrocyte, neuron or capillary endothelial cell and methods of using same. More specifically, antagonists of the NCCa-ATP channel are contemplated. The compositions are used to prevent cell death and to treat secondary damage associated with spinal cord injury.
Public/Granted literature
- US20060100183A1 Therapeutic agents targeting the NCCa-ATP channel and methods of use thereof Public/Granted day:2006-05-11
Information query
